Funding Opportunity Announcement
Now Accepting Applications
The Biostatistics, Epidemiology, and Research Design (BERD) Core of the Clinical and Translational Science Institute (CTSI) is now accepting applications for the Quantitative Methodologies Pilot Program (QuMP). This funding opportunity is designed to support research that involves interdisciplinary and translational use of quantitative methodologies, such as statistics, biostatistics, and epidemiology. Projects must either involve the novel use of an already existing quantitative methodology or the development of a new quantitative methodology.
The 2018 Cycle is focused on supporting graduate students and their faculty mentors working to develop novel quantitative methodologies
Not Currently Accepting Applications
Are you developing an idea for a research project that uses predictive or computational modeling to improve knowledge of health, medicine, and disease? You may be eligible for funding through CTSI’s Biomedical Modeling Pilot Awards. These awards provide pilot funding of up to $25,000 for trans-disciplinary collaborations that unite quantitative modeling with clinical and translational research. Applications are now being accepted – Submit your proposal before June 15!
The Special Populations program of the Clinical and Translational Science Institute is now accepting applications for the REAL Pilot Awards, a funding opportunity that offers investigators up to $25,000 for twelve months of direct costs. These pilots are being offered to encourage new research projects that examine the changes in biological and psychosocial mechanisms across the entire human lifespan.
This funding opportunity is for projects in the T1 or T2 stage of translational research (For further information on the T stages of research, see Blumberg et al. Nat Med 18: 35-41). T1/T2 phases of translational research move laboratory or preclinical discoveries into health practice by determining safety, efficacy, or performance of the discoveries in humans. Projects must involve human participation, as opposed to laboratory studies on mechanism discovery or pathophysiology.
T1 is described as research that yields knowledge about new methods of diagnosis, treatment and prevention. Pilot T1 studies might test whether interventions derived from basic research can produce effects in humans.
T2 is described as research that yields knowledge about the efficacy of interventions in optimal settings. Pilot T2 projects might test the feasibility of a controlled clinical trial or gather information essential to the design of a trial.
This funding opportunity is for projects in the T3 or T4 stage of translational research (For further information on the T stages of research, see Blumberg et al. Nat Med 18: 35-41). T3/4 phases of translational research address gaps in knowledge for interventions with proven efficacy and safety in optimal settings.
T3 is described as research that yields knowledge about how interventions work in real-world settings. Pilot T3 studies might explore whether interventions or strategies can be applied in general practice.
T4 is described as research that applies knowledge to improve population health. Pilot T4 projects might examine the impact of interventions or strategies on the prevalence of disease in a population or on the health of a population.
The Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh is now seeking applications for a new funding opportunity, CRISP (CTSI’s Research Initiative for Special Populations). Sponsored by CTSI’s Integrating Special Populations (ISP) program, CRISP offers campus investigators up to $25,000 in funding to support research initiatives that work with groups that are frequently underrepresented in research.